hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
Knee Osteochondritis Dissecans and the Preservation Pathway

Knee Osteochondritis Dissecans and the Preservation Pathway

What OCD of the Knee Actually Is

Osteochondritis dissecans — OCD for short — is neither arthritis nor a conventional fracture, and understanding the difference matters for what happens next. The condition begins in the subchondral bone: the layer of bone sitting immediately beneath the cartilage surface. When that bone loses sufficient blood supply, a focal segment can soften, separate, and — in more advanced cases — take the overlying cartilage with it as a loose fragment inside the joint.

The medial femoral condyle (the inner rounded base of the thigh bone) is the most commonly affected site, and the knee is the joint most often involved overall. OCD typically presents in active children, adolescents, and young adults, though it is not confined to that age group.

No single cause has been established. Research suggests that repetitive mechanical loading, vascular disruption, and biological vulnerabilities — including genetic factors and irregularities in how bone forms during growth — act together rather than in isolation.

One distinction threads through every treatment decision: whether the growth plates are still open. Juvenile OCD, occurring while the physes remain active, carries a meaningfully better chance of healing without surgery than adult OCD, where spontaneous recovery is uncommon. The earlier a lesion is identified, the larger that window of opportunity — particularly in younger patients, where the biology is still on their side.

Symptoms and When to Seek Assessment

Recognising OCD early is not straightforward. In the initial stages, the pain tends to be vague — a dull ache around the front or inner side of the knee that typically worsens with activity and eases with rest. Because this pattern overlaps with growing pains and common overuse complaints, OCD is frequently attributed to those causes first, and weeks or months can pass before the correct picture emerges.

As the condition progresses, swelling after sport or exercise becomes more noticeable, and the joint may feel stiff after a period of sitting or inactivity. These mid-stage signs still fall within the territory of conservative management, but they warrant investigation rather than further watchful waiting.

The symptoms that call for prompt specialist review are mechanical in character: a sensation of something catching or clicking inside the knee, an episode of the joint seeming to lock or give way, or pain that feels distinctly different from the background ache — sharper, more localised, triggered by a specific movement. These symptoms suggest the osteochondral fragment may have become unstable or detached, which changes the treatment calculus considerably.

Red flags that warrant specialist referral:

  • Knee pain persisting beyond a few weeks despite rest and activity reduction
  • Any mechanical symptoms — catching, locking, or sudden giving way
  • Swelling that recurs after exercise without a clear traumatic cause
  • Pain in an active adolescent that has been attributed to growing pains but is not settling

One further reason to seek thorough assessment early: approximately 15% of patients who present with pain in one knee have OCD in the other knee on imaging, even without symptoms there. In a cohort of 80 patients with a mean age of 13.1 years, 67% of those asymptomatic contralateral lesions ultimately required surgical intervention. This does not mean a second diagnosis is inevitable — but it does explain why a specialist may recommend imaging both knees at the initial consultation, rather than treating a single scan as the full picture.

Free non-medical discussion

Not sure what to do next?

Book a Discovery Call

Information only · No medical advice or diagnosis.

How OCD Is Diagnosed

Plain X-rays are the logical starting point when OCD is suspected — they can reveal subchondral lucency, flattening of the condylar surface, or a visible bony fragment in more advanced cases — but they have a clear limitation: cartilage itself does not appear on plain film. An X-ray may look near-normal in the early stages of the condition, even when the underlying bone is already compromised.

MRI closes that gap. It is the cornerstone of OCD assessment, providing information that plain imaging cannot: the state of the overlying cartilage, the size and depth of the lesion, the degree of subchondral oedema, and — most critically — whether the fragment is stable or has begun to separate. Stability status is the single most influential variable in deciding between conservative management and surgical intervention, so getting this assessment right matters enormously.

A 2025 MRI-based staging system for OCD demonstrates substantial interrater reliability, meaning different clinicians reviewing the same scan tend to reach consistent conclusions. It has also shown promise as a monitoring tool, able to track how far bone consolidation has progressed across sequential scans during healing — a meaningful clinical advantage over static assessment alone.

Because contralateral disease may be present even when the other knee is entirely asymptomatic, imaging both knees at first presentation is often clinically warranted. Picking up a silent lesion at an early, stable stage — before it progresses — preserves far more treatment options than discovering it later under duress.

Arthroscopy — direct visual inspection of the joint interior — is occasionally used as a diagnostic adjunct when MRI leaves genuine doubt about fragment stability, but it is not part of routine initial assessment. It belongs to the surgical decision pathway, and is reached only when imaging alone cannot resolve the clinical question.

The Four Stages and What Each Means for Treatment

Staging an OCD lesion does two things simultaneously: it describes what the bone and cartilage look like right now, and it points directly toward what treatment is most likely to work. Four stages are recognised, graded by how stable the fragment remains.

Stage I is the earliest, and in many respects the most treatable. The cartilage surface is intact; stress and altered blood supply have affected the subchondral bone beneath, but nothing has cracked or separated. On MRI this typically appears as bone oedema without any fracture line. At this stage — particularly in a child or adolescent with open growth plates — the bone retains meaningful capacity to remodel and recover with structured rest, activity modification, and protected weight-bearing.

Stage II introduces a partial fracture line beneath the cartilage, but the surface itself remains stable. The joint surface has not broken down. Conservative management is still the appropriate starting point for skeletally immature patients here, though the lesion warrants closer monitoring. The biological advantage of open physes — greater repair potential and ongoing skeletal growth — is at its most clinically relevant across these first two stages. This is the window where non-surgical management is most likely to close.

Stage III changes the calculation. The fragment has detached from its bed but remains in place within the joint — unstable, but not yet displaced. At this point, regardless of the patient's age, surgical intervention is generally indicated. The priority shifts to saving the fragment: cleaning the defect bed, grafting it biologically, and fixing the piece back down with sufficient rigidity to allow healing.

Stage IV is a loose body — the fragment has migrated into the joint space. Mechanical symptoms such as catching and locking follow, and surgery is required both to retrieve the fragment and to address the defect it has left behind.

The hinge between conservative and surgical pathways, then, is stability — confirmed by MRI signal characteristics or, where imaging is ambiguous, by arthroscopy. Skeletal maturity is the second variable that shapes which path is taken: the same Stage II lesion in a thirteen-year-old and a twenty-five-year-old will not be managed identically.

The Preservation Pathway from Conservative Care to Surgery

The approach to OCD follows a single organising principle — preserve as much as possible, at every stage — from the first weeks of conservative management through to surgical reconstruction.

Starting conservatively

For stable lesions (Stages I and II) in younger patients with open growth plates, non-surgical management is always the starting point: structured activity restriction, protected weight-bearing, temporary bracing where indicated, and supervised physiotherapy. The biological advantage of skeletal immaturity — discussed in the earlier section on staging — makes this window genuinely productive, and it is worth protecting rather than bypassing. Progress is confirmed on serial MRI at roughly three-monthly intervals.

The decision point arrives between three and six months. A lesion tracking toward consolidation stays the conservative course; one that is static or worsening triggers surgical review.

Escalation criteria

Four situations shift the pathway toward intervention: confirmed failure of supervised conservative management within that three-to-six-month window; unstable lesions (Stages III–IV) at presentation; closed physes, which remove the repair biology that makes conservative care viable in adolescents; and a symptomatic loose body producing mechanical symptoms in the joint.

Fragment preservation: the surgical priority

Where the fragment remains viable, the surgeon's first intention is to fix it back in place. Open reduction and internal fixation (ORIF) with bone grafting of the defect bed achieves approximately 79.5% radiological healing at six months across published series, with a clinical failure rate of around 9.1%. The strongest predictors of failure are pre-operative lesion instability and the residual unhealed area at six months — both arguments for timely rather than delayed fixation. Bioabsorbable magnesium alloy implants (MAGNEZIX®) remove the need for hardware removal surgery and achieved complete MRI union in 77.78% of paediatric cases at 24 months, with Lysholm scores averaging 87.6. Regardless of implant choice, the operative principles are consistent: rigid fixation, biological optimisation of the repair environment, and early controlled motion.

When reconstruction replaces preservation

Where the fragment is non-salvageable — more common in adult-onset disease or late-presenting cases — the aim shifts from fixing what exists to restoring what has been lost. Osteochondral autograft transplantation (OAT) transfers healthy bone-and-cartilage plugs from a low-load zone of the knee into the defect. Fresh osteochondral allograft uses donor tissue for larger defects, with 72% good-to-excellent outcomes at a mean 7.7 years in a cohort of 64 patients. Autologous chondrocyte implantation (ACI) harvests and expands the patient's own cartilage cells before reimplanting them — biologically appealing but requiring two operative stages. For appropriate earlier-stage lesions where the clinical aim is biologic support rather than structural reconstruction, a ChondroFiller injection — an injectable acellular collagen scaffold delivered as an ultrasound-guided outpatient treatment — recruits the patient's own progenitor cells to support matrix repair; whether this is suitable for a given case is a matter for specialist assessment.

Recovery Expectations and Long-Term Outlook

Recovery from OCD is not measured in weeks but in milestones: restored muscle symmetry, confidence under load, and the capacity to meet functional testing criteria before returning to sport. Published outcomes after OAT-augmented fixation in juvenile OCD give a realistic frame of reference — 84.6% of patients returned to their pre-injury sports level, with medial condyle lesions doing so in around 8.1 months on average against 12.9 months for lateral condyle cases. These figures reflect what is achievable under good conditions; they are not a guaranteed timeline for any individual.

The longer view carries an honest caveat. Some long-term studies note mild degenerative change on late follow-up imaging even after successful intervention — not a marker of treatment failure, but the reason monitoring continues past the point of clinical resolution. The aim of the preservation pathway is to reduce and delay that risk, not to abolish it entirely.

Evidence gaps are real and worth naming plainly. No head-to-head randomised trials have compared fixation implant types; long-term data beyond fifteen years for newer biodegradable implants remain limited; and ROCK-group multicentre studies are still accruing the volume needed to formalise decision-making algorithms. For patients making choices now, that translates into a practical point: staging, suitability, and the monitoring schedule should all be determined by a clinician working from the current evidence base rather than historical convention. Specialist assessment — available through the London Cartilage Clinic on Harley Street, the UK delivery centre for ChondroFiller injection and related cartilage pathways — is a sensible first step; details are at londoncartilage.com.

  1. [1] Osteochondritis Dissecans (JBJS, 2021). (2021). https://doi.org/10.2106/JBJS.20.01399 https://doi.org/10.2106/JBJS.20.01399
  2. [2] Osteochondritis Dissecans – Wikipedia. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029
  3. [3] Fixation of Osteochondral Lesions Using MAGNEZIX Implants in Pediatric Patients: Midterm Clinical and MRI Results (2025). (2025). https://doi.org/10.55095/achot2024/071 https://doi.org/10.55095/achot2024/071
  4. [4] An MRI-Based Staging System for OCD Demonstrates Substantial Interrater Reliability and Tracks Progressive Ossification During Healing (2025 preprint). (2025). https://doi.org/10.1101/2025.05.08.25326569 https://doi.org/10.1101/2025.05.08.25326569
  5. [5] Association of Stability and Size of Unhealed Area With Failure After Internal Fixation for OCD of the Knee (2024). (2024). https://doi.org/10.1177/03635465231217252 https://doi.org/10.1177/03635465231217252
  6. [6] Bilateral OCD of the Knee in Pediatric/Adolescent Patients Presenting with Unilateral Symptoms (2023). (2023). https://doi.org/10.1177/18632521231193711 https://doi.org/10.1177/18632521231193711
  7. [7] Functional Recovery and Clinical Outcome After Internal Fixation Using OAT for OCD of the Knee (2025). (2025). https://doi.org/10.1177/23259671241302125 https://doi.org/10.1177/23259671241302125

Frequently Asked Questions

  • OCD affects the subchondral bone beneath cartilage. When this bone loses blood supply, it softens and may separate, potentially causing overlying cartilage to detach as a loose fragment within the joint.
  • Mechanical symptoms warrant specialist review: catching, clicking, locking, giving way, or sharp pain triggered by specific movements. Also: persistent pain beyond weeks despite rest, or recurrent swelling without clear trauma.
  • MRI reveals cartilage condition, lesion size and depth, subchondral oedema, and crucially, whether the fragment is stable or separating. X-rays cannot show cartilage, making MRI the cornerstone diagnostic tool.
  • Stage III involves detachment but the fragment remains within the joint. Stage IV is a loose body that has migrated into the joint space, causing mechanical symptoms like catching and locking.
  • Yes. Approximately 15% of patients with symptomatic OCD in one knee have undetected OCD in the other. Imaging both knees at initial consultation is often warranted, as 67% of such silent lesions eventually required intervention.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
ChondroFiller injection for basal thumb and finger OA
09 Aug 2026

ChondroFiller injection for basal thumb and finger OA

ChondroFiller, a collagen scaffold injected into damaged thumb and finger joints, recruits the patient's own cells to rebuild cartilage rather than simply reducing inflammation or lubricating. Clinical evidence shows pain relief and measurable structural improvements — widened joint space on MRI — across early and advanced osteoarthritis stages.

ChondroFiller injection vs hyaluronic acid for knee relief
09 Aug 2026

ChondroFiller injection vs hyaluronic acid for knee relief

ChondroFiller, a collagen scaffold, stimulates cartilage regeneration in focal lesions; hyaluronic acid restores joint lubrication in diffuse wear. These structurally different treatments target distinct pathologies and outcomes.

Knee Osteochondritis Dissecans and the Preservation Pathway
09 Aug 2026

Knee Osteochondritis Dissecans and the Preservation Pathway

Osteochondritis dissecans begins when blood-starved subchondral bone separates beneath the cartilage surface; in children and adolescents, open growth plates enable healing through structured rest — but MRI-confirmed fragment stability is the determining factor.

ChondroFiller Injection Side Effects and Recovery
08 Aug 2026

ChondroFiller Injection Side Effects and Recovery

Swelling and pain within 48–72 hours of ChondroFiller injection settle without treatment; across 19,000 cases, the procedure shows zero serious adverse events and delivers sustained relief in 70–85% of patients with focal cartilage defects.

Hip preservation after labral tear with cartilage damage
08 Aug 2026

Hip preservation after labral tear with cartilage damage

Labral tears and cartilage damage occur together: the labrum and underlying cartilage share a mechanical boundary, so a force sufficient to tear one damages the other.

Are you a ChondroFiller injection candidate
08 Aug 2026

Are you a ChondroFiller injection candidate

ChondroFiller injection is an ultrasound-guided injectable collagen scaffold that recruits the patient's progenitor cells to promote cartilage formation; candidacy assessment routes patients to the appropriate protocol tier rather than applying binary disqualifications based on defect size or osteoarthritis grade.

Privacy & Cookies Policy